Levosimendan in ECMO: A Paradigm Shift or an Adjunctive Option?
Levosimendan, a calcium-sensitizing inodilator, has emerged as a promising adjunctive therapy in patients undergoing veno-arterial extracorporeal membrane oxygenation (V-A ECMO). Its pharmacodynamic profile, combining positive inotropy with vasodilation and mitochondrial protective effects, offers a...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2025-12-01
|
| Seri Bilgileri: | Future Pharmacology |
| Konular: | |
| Online Erişim: | https://www.mdpi.com/2673-9879/5/4/70 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|